Daniel Lewis

Daniel Lewis is an NIHR Clinical Lecturer in the Division of Cancer Sciences, specializing in neuro-oncology with a focus on vestibular schwannoma using advanced MRI and PET imaging techniques.

His educational qualifications include a PhD, MA, MRCS, and MRCP, reflecting dual expertise in clinical medicine and academic research.

Research interests center on quantitative imaging biomarkers for tumor growth prediction, neuroinflammation in vestibular schwannoma microenvironments, and multimodal imaging validation. His work bridges clinical neurology and radiological innovation to develop non-invasive monitoring tools for tumor behavior.

Recent publications demonstrate a clear trend toward integrating dynamic contrast-enhanced MRI with diffusion-weighted and PET techniques to establish predictive models for tumor progression and treatment response in acoustic neuroma.

Scientific recognition includes:

• NIHR Clinical Lectureship

As a Clinical Lecturer, Lewis actively supervises research while maintaining clinical practice, evidenced by his PhD supervision under Prof. Jackson and Prof. King. His collaborative network spans neurosurgery, radiology, and molecular imaging teams across institutional boundaries.

He contributes to national research initiatives through dataset development like the Low Dose T1W DCE-MRI pilot study, advancing perfusion measurement methodologies in neuro-oncology.